Praram 9 Hospital PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	5,150	4,649	4,216	4,122	3,000	2,613
Other Revenue	58.44	41.51	36.86	28.16	26.12	19.93
Revenue	5,209	4,691	4,253	4,150	3,026	2,633
Revenue Growth (YoY)	13.11%	10.29%	2.47%	37.16%	14.93%	-8.46%
Cost of Revenue	3,279	3,045	2,820	2,724	2,172	1,890
Gross Profit	1,929	1,645	1,433	1,427	853.75	743.22
Selling, General & Admin	1,005	837.22	773.68	735.1	557.21	518.42
Operating Expenses	1,005	837.22	773.68	735.1	557.21	518.42
Operating Income	923.83	807.89	659.09	691.81	296.53	224.8
Interest Expense	-0.58	-0.49	-0.64	-0.48	-0.48	-0.47
Interest & Investment Income	55.05	54.62	30.17	8.72	4.21	5.94
Pretax Income	978.31	862.01	688.63	700.05	300.27	230.28
Income Tax Expense	165.95	149.33	130.77	132.44	51.1	28.22
Net Income	812.36	712.68	557.86	567.61	249.17	202.05
Net Income to Common	812.36	712.68	557.86	567.61	249.17	202.05
Net Income Growth	17.03%	27.75%	-1.72%	127.80%	23.32%	-28.97%
Shares Outstanding (Basic)	786	786	786	786	786	786
Shares Outstanding (Diluted)	786	786	786	786	786	786
EPS (Basic)	1.03	0.91	0.71	0.72	0.32	0.26
EPS (Diluted)	1.03	0.91	0.71	0.72	0.32	0.26
EPS Growth	17.03%	27.75%	-1.72%	127.80%	23.32%	-28.97%
Free Cash Flow	682.51	804.87	514.74	736.32	344.49	-304.26
Free Cash Flow Per Share	0.87	1.02	0.66	0.94	0.44	-0.39
Dividend Per Share	0.650	0.400	0.300	0.290	0.140	0.110
Dividend Growth	44.44%	33.33%	3.45%	107.14%	27.27%	-21.43%
Gross Margin	37.04%	35.07%	33.69%	34.38%	28.21%	28.23%
Operating Margin	17.74%	17.22%	15.50%	16.67%	9.80%	8.54%
Profit Margin	15.60%	15.19%	13.12%	13.68%	8.23%	7.67%
Free Cash Flow Margin	13.10%	17.16%	12.10%	17.74%	11.39%	-11.56%
EBITDA	1,216	1,097	941.45	974.8	570.13	416.91
EBITDA Margin	23.34%	23.39%	22.14%	23.49%	18.84%	15.83%
D&A For EBITDA	292.11	289.25	282.35	282.98	273.6	192.11
EBIT	923.83	807.89	659.09	691.81	296.53	224.8
EBIT Margin	17.74%	17.22%	15.50%	16.67%	9.80%	8.54%
Effective Tax Rate	16.96%	17.32%	18.99%	18.92%	17.02%	12.26%
Revenue as Reported	5,209	4,691	4,253	4,150	3,026	2,633

Source: S&P Global Market Intelligence. Standard template. Financial Sources.